Plozasiran, an RNA Interference Agent Targeting APOC3, for Mixed Hyperlipidemia
Arrowhead Pharmaceuticals
Christie M Ballantyne; Szilard Vasas; Masoud Azizad; Peter Clifton; Robert S Rosenson; Ting Chang; Stacey Melquist; Rong Zhou; Ma'an Mushin; Nicholas J Leeper; Jennifer Hellawell; Daniel Gaudet